What is Polaryx Therapeutics, Inc. 's accrued liabilities, current?

Polaryx Therapeutics, Inc. (PLYX) reported accrued liabilities, current of $45.00K in Q1 2026.

What does accrued liabilities, current mean?

Short-term expenses that have been incurred but not yet paid.

Polaryx Therapeutics, Inc. Accrued Liabilities, Current increased by 95.7% to $45.00K in Q1 2026 compared to the prior quarter.

StatementBalance Sheet Statement

SectionCurrent Liabilities

CategoryLiquidity

SignalContext dependent

VolatilityModerate

First reportedQ4 2025

Last reportedQ1 2026

A steady increase relative to revenue may indicate rising operational costs or changes in payment timing.

These are short-term obligations for expenses that have been incurred but not yet invoiced or paid by the end of the rep...

Standard across all industries for tracking short-term operational obligations.

Metric ID: current_liabilities_accrued_liabilities_current

2 periods

	Q4 '25	Q1 '26
Value	$23.00K	$45.00K
QoQ Change	—	+95.7%

Range$23.00K – $45.00K

What is Polaryx Therapeutics, Inc. 's accrued liabilities, current?: Polaryx Therapeutics, Inc. (PLYX) reported accrued liabilities, current of $45.00K in Q1 2026.
What does accrued liabilities, current mean?: Short-term expenses that have been incurred but not yet paid.